Free Trial
NASDAQ:RKDA

Arcadia Biosciences (RKDA) Stock Price, News & Analysis

Arcadia Biosciences logo
$4.75 +0.12 (+2.59%)
Closing price 07/3/2025 03:25 PM Eastern
Extended Trading
$4.65 -0.10 (-2.11%)
As of 07/3/2025 04:25 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Arcadia Biosciences Stock (NASDAQ:RKDA)

Key Stats

Today's Range
$4.46
$5.19
50-Day Range
$3.45
$5.10
52-Week Range
$2.40
$10.31
Volume
79,150 shs
Average Volume
310,294 shs
Market Capitalization
$6.51 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$6.00
Consensus Rating
Buy

Company Overview

Arcadia Biosciences Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
26th Percentile Overall Score

RKDA MarketRank™: 

Arcadia Biosciences scored higher than 26% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Arcadia Biosciences has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Arcadia Biosciences has received no research coverage in the past 90 days.

  • Read more about Arcadia Biosciences' stock forecast and price target.
  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Arcadia Biosciences is -1.11, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Arcadia Biosciences is -1.11, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Arcadia Biosciences has a P/B Ratio of 1.04. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about Arcadia Biosciences' valuation and earnings.
  • Percentage of Shares Shorted

    1.64% of the float of Arcadia Biosciences has been sold short.
  • Short Interest Ratio / Days to Cover

    Arcadia Biosciences has a short interest ratio ("days to cover") of 1.8, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Arcadia Biosciences has recently increased by 67.67%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Arcadia Biosciences does not currently pay a dividend.

  • Dividend Growth

    Arcadia Biosciences does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    1.64% of the float of Arcadia Biosciences has been sold short.
  • Short Interest Ratio / Days to Cover

    Arcadia Biosciences has a short interest ratio ("days to cover") of 1.8, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Arcadia Biosciences has recently increased by 67.67%, indicating that investor sentiment is decreasing significantly.
  • Search Interest

    Only 1 people have searched for RKDA on MarketBeat in the last 30 days. This is a decrease of -67% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Arcadia Biosciences insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 1.80% of the stock of Arcadia Biosciences is held by insiders.

  • Percentage Held by Institutions

    Only 17.73% of the stock of Arcadia Biosciences is held by institutions.

  • Read more about Arcadia Biosciences' insider trading history.
Receive RKDA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Arcadia Biosciences and its competitors with MarketBeat's FREE daily newsletter.

RKDA Stock News Headlines

RKDA Arcadia Biosciences, Inc.
"I'm risking my reputation on this"
Behind closed doors, away from the mainstream media's eyes, the smartest minds in crypto are all seeing the same signals. They're positioning themselves for something unprecedented. And after 17 million podcast downloads and over 600 insider interviews, I finally connected all the dots… What I discovered was so explosive, so potentially life-changing, that I had to put it all in a book.
Arcadia Climbs on Q1 Figures
See More Headlines

RKDA Stock Analysis - Frequently Asked Questions

Arcadia Biosciences' stock was trading at $5.92 at the beginning of the year. Since then, RKDA stock has decreased by 19.8% and is now trading at $4.75.

Arcadia Biosciences, Inc. (NASDAQ:RKDA) posted its quarterly earnings results on Thursday, May, 8th. The basic materials company reported $1.90 earnings per share for the quarter, beating the consensus estimate of ($0.98) by $2.88. The basic materials company had revenue of $1.20 million for the quarter, compared to analyst estimates of $1.60 million. Arcadia Biosciences had a negative trailing twelve-month return on equity of 16.94% and a negative net margin of 38.34%.
Read the conference call transcript
.

Shares of Arcadia Biosciences reverse split on the morning of Wednesday, January 24th 2018.The 1-20 reverse split was announced on Tuesday, January 23rd 2018. The number of shares owned by shareholders was adjusted after the market closes on Tuesday, January 23rd 2018. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

Arcadia Biosciences (RKDA) raised $66 million in an IPO on Friday, May 15th 2015. The company issued 8,200,000 shares at $8.00 per share. Credit Suisse, J.P. Morgan and Piper Jaffray acted as the underwriters for the IPO.

Shares of RKDA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Arcadia Biosciences investors own include NVIDIA (NVDA), Meta Platforms (META), PayPal (PYPL), GE Aerospace (GE), Arista Networks (ANET), Advanced Micro Devices (AMD) and CrowdStrike (CRWD).

Company Calendar

Last Earnings
5/08/2025
Today
7/05/2025
Next Earnings (Estimated)
8/12/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Agriculture
Current Symbol
NASDAQ:RKDA
Employees
60
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$6.00
High Stock Price Target
$6.00
Low Stock Price Target
$6.00
Potential Upside/Downside
+26.3%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$7.04 million
Pretax Margin
-14.51%

Debt

Sales & Book Value

Annual Sales
$5.05 million
Price / Cash Flow
N/A
Book Value
$4.56 per share
Price / Book
1.04

Miscellaneous

Free Float
1,342,000
Market Cap
$6.51 million
Optionable
Not Optionable
Beta
0.50

Social Links

The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report

This page (NASDAQ:RKDA) was last updated on 7/5/2025 by MarketBeat.com Staff
From Our Partners